Replies to post #50614 on Anavex Life Sciences Corp (AVXL)

[sokol]

I agree completely and add this: Biotech has been volatile over the past year the past year or so because of the political uproar associated with soaring drug costs. This volatility was spurred by comments by the head of the FDA and some presidential candidates, which will soon be forgotten. This has resulted in the average investor running to dump their biotech shares. On the other hand, this is when these stocks go on sale, and a time when the better investors make bigger additons. Biotech and Healthcare stocks are where the big additions will be made. Also, with share prices beaten down, I think there will be more mergers and acquisitions.